Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Sarepta Therapeutics Inc (SRPT)

NASDAQ
Currency in USD
Disclaimer
130.23
+1.98(+1.54%)
Closed
After Hours
130.50+0.27(+0.21%)

SRPT Comments

Their new medication will be approved in 2020.
Should.i buy at dip.or sell it off
Buy the dips but at small amounts of shares.
 thank you
Idk what.to do now
this company can change the world
the results this morning were very positive hence the 10% gain so far
this company is a winner in all ways, be very interesting to see after market data
a new Gene therapy is going to get unveiled soon by sarepta... stocks will b up by double the size
buy sarepta... this stock is going to go up
Why is Sarepta getting ***ed so badly?
100
88
This is a "must-buy" stock in 2017. Sure to be taken out by a big pharma at around $80
I am speculative on this one around 29-30, started with a quarter position at 32 yesterday.. I hope so after yesterday 5% down day.....may buy another quarter by eod. if it hovers the 30 zone....
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.